Abstract:Context . p53 mutation is associated with poor prognosis in breast cancer patients. Mutations in different structural and functional domains of p53 have different effects on its biological activities. Nevertheless, few studies have examined the full spectrum of p53 gene mutations in relation to breast cancer survival. Objective . To evaluate the prognostic significance of the types, localizations, and multiplicity of p53 gene mutations in breast cancer patients. Design, setting, and participants . Prospective cohort study of a consecutive series of 271 women with histologically confirmed primary breast cancer who underwent breast resection at the Jackson Memorial Hospital, Miami, FL, between 1984 and 1986. Main outcome measures . Ten year overall and breast-cancer-specific deaths. Results . After adjustment for tumor stage, treatment regimen, and the number of mutations, patients with p53 mutations had significantly greater breast-cancer-specific mortality than did patients without p53 mutations (hazard ratio = 2.86; 95% confidence interval: 1.15–7.11). Further analysis of mutation characteristics showed that patients with the following mutations had significantly poorer breast cancer disease-free survival: silent/missense mixed mutations (7.95; 1.28–49.62), nonsense mutations (9.43; 1.29–69.12), transitions (3.79; 1.46–9.88), mutations in which guanine changed (3.32; 1.01–10.35), and mutations on exon 7 (6.46; 1.78–23.45). Conclusions . Breast-cancer-specific and all-cause mortality are increased in female breast cancer patients with the following p53 mutation characteristics: silent and missense mixed mutations, transitional mutations, mutations in which guanine changed, mutations on exon 7, or multiple mutations occurring within 60 codons. These findings indicate that not just p53 mutation per se but the full spectrum (i.e., different types, locations, and numbers) of p53 mutation needs to be examined when it is used as a prognostic marker of survival in breast cancer patients.

New approaches to understanding p53 gene tumor mutation spectra

Modeling the Etiology of p53-mutated Cancer Cells

P53 Gain-of-Function: Tumor Biology and Bioinformatics Come Together

Dipeptide Analysis of P53 Mutations and Evolution of P53 Family Proteins

Functional Diversity of P53 in Human and Wild Animals

Biological Effects of p53 Mutation W248 and H175 on MCF-7 Cells

Gain of Function of P53 Cancer Mutants in Disrupting Critical DNA Damage Response Pathways

Mutant p53 in cancer: from molecular mechanism to therapeutic modulation

Significant Prognostic Features and Patterns of Somatic TP53 Mutations in Human Cancers

Spectrum of p53 Tumor Suppressor Gene Mutations and Breast Cancer Survival

p53: 800 million years of evolution and 40 years of discovery

Putting p53 in Context

Bioinformatics study of cancer-related mutations within p53 phosphorylation site motifs.

Integrating mutation data and structural analysis of the TP53 tumor‐suppressor protein

Mutant p53: it’s not all one and the same

Unequal Prognostic Potentials of P53 Gain-of-function Mutations in Human Cancers Associate with Drug-Metabolizing Activity.

Ordered and deterministic cancer genome evolution after p53 loss

Genetic Mechanisms of Tumor Suppression by the Human p53 Gene

Do Mutations Turn P53 Into An Oncogene?

[Advances on Mutant P53 Research].

Unraveling The Allosteric Mechanism Of Four Cancer-Related Mutations In The Disruption Of P53-Dna Interaction